Giovanni Palladini

University of Pavia — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

77h-index23.3kcitations620works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes(462), Parathyroid Disorders and Treatments(106), Multiple Myeloma Research and Treatments(65), Neuroendocrine Tumor Research Advances(50), Drug Transport and Resistance Mechanisms(46)

Publications619 total

New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System
Journal of Clinical Oncology·2025Open Access
Monitoring Disease Progression in Patients With Transthyretin Amyloid Cardiomyopathy
JACC Heart Failure·2025Open Access
A new validated staging system for AL amyloidosis with stage IIIc defining an ultra-poor prognostic in systemic AL amyloidosis in the modern treatment era
Blood·2025
Exploring light chain cardiotoxicity in AL amyloidosis: Impact on hiPSC-derived Cardiomyocyte Activity
2025Open Access
Dangerous clones with complex ties to AL amyloidosis
Blood·2025Open Access
A cautionary case series: tafamidis mistreatment following erroneous diagnosis of transthyretin cardiac amyloidosis
Amyloid·2025
Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis
JACC CardioOncology·2025· 3 citedOpen Access
Clonotypic B Cells are Passengers During Malignant Transformation and not Drivers of Disease Progression in Plasma Cell (PC) Neoplasms
Clinical Lymphoma Myeloma & Leukemia·2025
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis
JACC Heart Failure·2025· 4 citedOpen Access
Modeling immunoglobulin light chain amyloidosis in <i>Caenorhabditis elegans</i>
Disease Models & Mechanisms·2025· 1 citedOpen Access
Il ruolo della N-glicosilazione nelle catene leggere immunoglobuliniche nell'amiloidosi AL
Biochimica Clinica·2025· 1 cited
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid Cardiomyopathy
Circulation Heart Failure·2025· 1 citedOpen Access
NEUROHORMONAL THERAPIES AT BASELINE AND FOLLOW–UP AND SURVIVAL IN PATIENTS WITH WILD–TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS
European Heart Journal Supplements·2025
Change in prevalence of ATTR variants in Italy: results from a national survey
European Heart Journal - Quality of Care and Clinical Outcomes·2025· 7 cited
Quantitative <scp>MRI</scp> Assessment Using Variable Echo Time Imaging of Peripheral Nerve Injury in <scp>ATTRv</scp> Amyloidosis Patients
European Journal of Neurology·2025· 1 citedOpen Access
Author response: A conformational fingerprint for amyloidogenic light chains
2025· 1 citedOpen Access
Daratumumab‐based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case‐control study
HemaSphere·2025· 3 citedOpen Access
Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study
Blood Advances·2025· 1 citedOpen Access
A conformational fingerprint for amyloidogenic light chains
2025· 2 citedOpen Access
Author response: A conformational fingerprint for amyloidogenic light chains
2025Open Access
page 1 of 31Next →

Frequent Co-authors

Giampaolo Merlini(45), Laura Obici(18), Paolo Milani(14), Stefano Perlini(11), Andrea Foli(11), Francesca Lavatelli(11), Ashutosh Wechalekar(10), Vittorio Perfetti(9), Stefan Schönland(7), Raymond L. Comenzo(7), Efstathios Kastritis(7), Catherine Klersy(7), Vaishali Sanchorawala(7), Remigio Moratti(7), Philip N. Hawkins(6), Meletios Α. Dimopoulos(6), Arnaud Jaccard(6), Angela Dispenzieri(5), Ute Hegenbart(5), Paola Russo(5)